ISOPP CAPhO Symposium 2025

Oral Chemotherapy Management Workshop

Oral Chemotherapy Management Workshop

Visit the Registration page for information on fees and how to register. 

Back by popular demand from CAPhO 2024!

Thursday, April 3, 2025, 08:30-12:30
Victoria Conference Centre
Available to CAPhO members and non-members

Oral anti-cancer agents are becoming an increasingly common treatment option in the oncology setting. Although these medications are more convenient for patients, they also come with a number of challenges that include issues with drug access, adherence, toxicity and interactions. If you are involved in providing care to patients receiving oral anti-cancer agents, or would like more information on these medications, then CAPhO’s Oral Chemotherapy Management workshop is for you. Join us as we work through three patient cases (these cases will be different than the cases last year) and identify how pharmacists can help remove barriers for patients receiving these treatments. 

Participants will be provided with pre-workshop resources and cases to review in advance. During the workshop, our facilitators will provide a short overview of toxicities associated with three classes of oral anti-cancer agents (the workshop will review different classes of oral anti-cancer agents this year). You will then build on this knowledge as you are guided you through managing treatment complications with the use of interactive patient cases. 

Learning Objectives: 
By the end of this workshop, the participant will be able to: 

  1. Describe the toxicities associated with select classes of oral anti-cancer medications
  2. Identify strategies for managing toxicities and drug interactions associated with oral anti-cancer agents
  3. Describe the role of the pharmacist in caring for patients who are receiving oral anti-cancer agents
  4. Discuss methods for implementing oral anti-cancer management into your clinical practice

Facilitators

Workshop Presenters

Photo of Scott Edwards
Photo of Scott Edwards
Scott Edwards
Clinical Pharmacy Specialist, Pharmacy, Eastern Health, Canada
Scott Edwards is currently the Clinical Oncology Pharmacy Specialist at the Dr. H. Bliss Murphy Cancer Center in St. John’s, Newfoundland. He is also an assistant professor at the School of Pharmacy and the Discipline of Oncology, Faculty of Medicine, Memorial University of Newfoundland. He is active in clinical cancer research in the area of chemotherapy toxicities, supportive care and oral chemotherapy adherence. He graduated from Memorial University of Newfoundland with a B.Sc. (Neuroscience) in 1994 and a B.Sc (Pharmacy) in 1997. In 2005, he graduated with a Doctor of Pharmacy degree from the University of Washington. He completed a Master’s degree in Oncology from Newcastle University in 2015.
Photo of Scott Edwards
Clinical Pharmacy Specialist
Scott Edwards
 
Created with Lunacy
Photo of Michael LeBlanc
Photo of Michael LeBlanc
Michael LeBlanc
Director of Pharmacy Professional Practice, Horizon Health Network, Canada

Michael LeBlanc is Director of Pharmacy Professional Practice for Horizon Health Network, New Brunswick. He is responsible for the development, evaluation and monitoring of clinical pharmacy services. He graduated from Memorial University of Newfoundland in 1998 and received his PharmD from Idaho State University in 2009. Michael has been an oncology pharmacist for 25 years with a focus on the prevention and management of cancer-treatment associated toxicities. He is active in practice-based research and providing support for patients receiving oral anticancer medications. Michael is a member of the CAPHO Research Committee, FCAPHO Task Force, ambulatory oncology cpKPI working group, and the CAPHO24 Planning Committee.

He is also active in the Canadian Society of Hospital Pharmacists where he gained fellowship status in 2015 and is the current chair of the Board of Trustees for the CSHP Research and Education Foundation.

Photo of Michael LeBlanc
Director of Pharmacy Professional Practice
Michael LeBlanc
 
Created with Lunacy
Photo of Christine Peragine
Photo of Christine Peragine
Christine Peragine
Lead Pharmacist, Oral Anticancer Medication Program, Pharmacy, Sunnybrook Health Sciences Centre, Canada

Dr. Christine Peragine is the Lead Pharmacist for Sunnybrook’s Oral Anticancer Medication (OAM) Program at the Odette Cancer Centre, Toronto, Ontario, Canada. Christine graduated from the University of Toronto combined BScPhm-PharmD program in 2015 and started her PhD training and Antimicrobial Stewardship-Infectious Disease Pharmacy Fellowship in the same year. She has worked in Ambulatory Oncology since 2018 and is passionate about advancing pharmacy practice, research, and education. Over the course of her career, Dr. Peragine has spearheaded over 25 practice-based research initiatives, published over 30 unique abstracts, and presented at over 15 academic conferences. She has received over $110,000 CAD in grant funding and was the recipient of the 2022 Sunnybrook Practice-Based Research and Innovation Award of Inquiry. Her commitment to teaching is demonstrated by the number of students and trainees she has precepted (>30), and the creation and launch of clinical and research co-op opportunities with the OAM Team in Fall 2022.

Photo of Christine Peragine
Lead Pharmacist, Oral Anticancer Medication Program
Christine Peragine
 
Created with Lunacy